Medtech eyes pharma on EU product info move
This article was originally published in Clinica
Executive Summary
A development concerning the pharmaceutical industry being able to provide drug information directly to the public, within the confines of the current ban on advertising prescription medicines to consumers, may well have future implications for the medical devices and diagnostics industry.